Searchable abstracts of presentations at key conferences in endocrinology

ea0015p57 | Clinical practice/governance and case reports | SFEBES2008

Hyperglycaemia and ketoacidosis due to insulinoma

Thomas Manoj , Gable David , Ahlquist James

A 79-year-old lady presented with a 6 months history of confusion and slurred speech and was found to have recurrent spontaneous hypoglycaemia (plasma glucose 1.3, 1.8 and 2.6 mmol/l). Pituitary and adrenal function were normal, and raised insulin (102 pmol/l) and C-peptide (630 pmol/l) levels confirmed the diagnosis of insulinoma, which was identified as a solitary 2 cm mass in the head of pancreas. Treatment with diazoxide 100–150 mg tds led to normalisation of g...

ea0015p67 | Clinical practice/governance and case reports | SFEBES2008

Acromegaly in a patient with bronchial carcinoid complicated by oesophageal varices

Livingstone Kerry , Sawers Hilary , James Andy

We present the case of assumed ectopic GHRH from residual bronchial carcinoid on the basis of an elevated serum GH, an elevated IGF-1 impaired glucose tolerance and an acromegalic appearance. The patient was diagnosed with a left bronchial carcinoid in 1985, aged38 years. Treated with a left pneumonectomy. She remained well until she presented in 1994 with an oesophageal variceal bleed. She had no evidence of portal hypertension or liver disease. CT chest revealed a mediastina...

ea0015p78 | Clinical practice/governance and case reports | SFEBES2008

Zoledronate associated severe hypocalcaemia causing bradyarrhythmia that required urgent cardiac pacing

Bdiri Ashref , Lawrence James , Jones A , Smith Martin

A 71-year-old man with carcinoma of prostate and bony metastasis, presented with acute bradyarrhythmia, severe hypocalcaemia and acute renal failure 72 h after intravenous infusion of zoledronate. Before therapy, serum calcium was 2.14 mmol/l (normal, 2.10–2.55 mmol/l), serum phosphate 1.4 mmol/l (normal, 0.8–1.5 mmol/l), serum creatinine 95 umol/l and eGFR 74 ml/min. 25OH vitamin D was not measured. Three days later he presented with a syncopal episode. Initial bloo...

ea0015p87 | Clinical practice/governance and case reports | SFEBES2008

Sarcoidosis associated hypercalcaemia and renal failure mimicking lymphoma

Bdiri Ashref , Smith Martin , Lawrence James

We describe two cases of sarcoidosis associated hypercalcaemia, renal failure and anaemia mimicking lymphoma. The diagnosis was made by lymph node biopsy. Within weeks of starting oral steroids, symptoms resolved and biochemical abnormalities almost normalized.Case 1: A 66-year-old lady, presented with generalized weakness, lymphadenopathy and splenomegaly. Hb 96 g/l, MCV 91, urea 16.6 mmol/l, creatinine 227 umol/l, eGFR 15 ml/min, serum calcium 3.4 mmol...

ea0015p343 | Thyroid | SFEBES2008

Successful discontinuation of treatment after 16 years of replacement therapy with thyroxine in congenital hypothyroidism

Talapatra Indrajit , Scott Ian , Tymms David James

We describe below a 16-year-old male referred with neonatal hypothyroidism. He was commenced on levothyroxine at the age of 3 weeks. The TSH was >100 IU/l (normal: 0.27–4.7) and Total T4 was <10 nmol/l (normal: 60–150) and there was no uptake on thyroid isotope scanning. He was diagnosed as having congenital absence of thyroid tissue and given levothyroxine and the dose adjusted to maintain normal thyroid function. His mother was diagnosed with hypothyroidism...

ea0013p15 | Bone | SFEBES2007

Hypercalcaemia from vitamin D supplements and parathyroid autonomy: the hazards of DIY therapeutics

Ahlquist James , Cranfield Lesley , Corns Cathryn

Vitamin D toxicity is a recognised consequence of vitamin D therapy arising from prescription of pharmacological doses of vitamin D; biochemical monitoring is recommended for these patients. In contrast, patients taking low-dose calcium and vitamin D (Ca+D) supplements, commonly used to reduce the risk of osteoporosis, are not regarded as at risk of vitamin D toxicity, and biochemical monitoring is not routine. We report a patient taking Ca+D supplements who developed hypercal...

ea0013p192 | Diabetes, metabolism and cardiovascular | SFEBES2007

Use of Octreotide in the dumping syndrome – Diabetes mellitus or disordered insulin secretion – a diagnostic dilemma?

Bhattacharya Beas , Advani Andrew , James Andy

Fasting blood glucose is key to diagnosing diabetes, whilst the Oral Glucose Tolerance Test (OGTT) is a valuable adjunct when diagnosis is borderline or inconclusive. The OGTT is often used to detect early changes in glucose tolerance and predict a likely path to overt Diabetes Mellitus for example in gestational diabetes.A 42 year old female, referred to the Endocrine services for episodes of symptomatic hypoglycaemia. Past medical history included pylo...

ea0012p53 | Diabetes, metabolism and cardiovascular | SFE2006

Proglucagon processing can be altered to produce GLP-1 in pancreatic alpha cells

James NM , Pritchard LE , Brennand JC , White A

The proglucagon-derived hormone, glucagon-like peptide–1 (GLP-1), augments both beta cell function and mass. However, GLP-1 is rapidly degraded in plasma, thereby limiting its potential as a treatment for diabetes. One approach to circumvent this problem would be to stimulate synthesis of GLP-1 locally in the islet.Emerging evidence suggests that pancreatic alpha cells, which normally produce glucagon, can adapt to produce GLP-1. This phenomenon may...

ea0011p79 | Clinical case reports | ECE2006

Ophthalmic presentations of Cushing’s syndrome

Ibrahim IM , Al-Bermani A , James RA

Introduction: Central Serous Retinopathy (CSR) is a condition characterized by the accumulation of sub-retinal fluid at the posterior pole of the fundus, creating a circumscribed area of serous retinal detachment. It is associated with increased levels of endogenous or exogenous glucocorticoids and has been described in patients with Cushing’s syndrome (CS).Here we report on two cases we recently managed in our unit, with central serous retinopathy ...

ea0007p251 | Clinical case reports | BES2004

Adrenal insufficiency as the second clinical manifestation of the primary antiphospholipid antibody syndrome

Abouglila K , James A , Stevenson M , Hanley J

Antiphospholipid antibody syndrome is characterised by recurrent venous or arterial thrombosis, thrompocytopenia and/or recurrent fetal loss in the presence of antiphospholipid antibodies. Antiphospholipid antibody syndrome may be seen in-patients with established Systemic Lupus Erythematosus or alternatively as isolated disease in-patients with no evidence of a lupus type abnormality. Antiphospholipid antibodies have been also associated with a variety of neurological and car...